Filter
1398
Filtered Results: 1398
Text search:
pharmacy
management
Featured
Recommendations
139
New Publications
489
Language
Document type
No document type
808
Guidelines
225
Studies & Reports
211
Manuals
68
Strategic & Response Plan
33
Training Material
23
Fact sheets
15
Situation Updates
7
Online Courses
3
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
Kenya
76
Ethiopia
62
India
60
South Africa
51
Sierra Leone
46
Nigeria
44
Uganda
39
Rwanda
36
Liberia
36
Tanzania
35
Nepal
34
Ghana
34
Zambia
31
Malawi
29
Namibia
29
Global
26
Bangladesh
23
Lesotho
18
Zimbabwe
18
Botswana
18
Western and Central Europe
17
Ukraine
16
Latin America and the Carribbean
15
Myanmar / Burma
15
Indonesia
12
Congo, Democratic Republic of
11
Cameroon
9
Senegal
9
Burkina Faso
9
Philippines
9
Mozambique
8
Africa
8
Eswatini/ Swaziland
8
South–East Asia Region
7
South Sudan
7
Syria
6
Guinea
6
Haiti
6
Cambodia
6
Russia
6
Tajikistan
5
Benin
5
Germany
5
Eastern Europe and Central Asia
5
Brazil
5
Jordan
4
West and Central Africa
4
United Kingdom
4
Mali
4
Pakistan
4
Thailand
3
Chile
3
Afghanistan
3
Asia
3
Middle East and North Africa
3
East and Southern Africa
3
Vietnam
3
Eastern Europe
3
Moldova
3
Central African Republic
3
Bhutan
3
Timor Leste/ East Timor
2
Serbia
2
China
2
Albania
2
Peru
2
Armenia
2
Venezuela
2
Western Pacific Region
2
France
2
Portugal
2
Spain
2
Lebanon
2
Sri Lanka
2
Sudan
2
Yemen
2
Georgia
2
Angola
2
Libya
2
North Macedonia
1
Colombia
1
Mexico
1
Turkey
1
Australia
1
Gambia
1
Kazakhstan
1
Canada
1
Laos
1
Kyrgyzstan
1
Uzbekistan
1
Morocco
1
Qatar
1
Italy
1
USA
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Egypt
1
Palestine
1
Chad
1
Iraq
1
Somalia
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
769
Clinical Guidelines
75
Public Health
53
Key Resources
40
Women & Child Health
39
Capacity Building
29
Pharmacy & Technologies
20
Annual Report MEDBOX
1
Toolboxes
Pharmacy
148
AMR
132
HIV
89
COVID-19
63
TB
61
Mental Health
35
Caregiver
34
Ebola
24
NCDs
24
Rapid Response
21
Conflict
19
NTDs
13
Planetary Health
12
Disability
8
Global Health Education
8
Natural Hazards
7
Refugee
6
Health Financing Toolbox
4
Specific Hazards
3
Zika
3
Cholera
2
Polio
2
The Ghanaian Cabinet approved the antimicrobial resistance (AMR)Policy and Implementation plan(hereafter referred to as the national action plan or NAP)in December 2017, whilst the country case study was in progress. This has set in motion the implementation phase for Ghana, which is a long awaited...
While infections that develop during hospitalization may appear to be an uncommon but recognized risk of hospital care today, the incidence of these infections has been increasing dramatically during the last 2 to 3 decades, and the risk of acquiring an organism that is resistant to 1 or more antibi...
Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe) classification could facilitate simple stewardship interventions that are widely applicable globally....
A guide for practical implementation in adult and pediatric emergency department and urgent care settings
ຢາຕ້ານເຊື້ອຈຸລະຊີບ (Antimicrobial medicines) ມີຄວາມສໍາຄັນຫຼາຍຕໍ່ວຽກງານການແພດ, ສາທາລະນະສຸກ, ສຸຂະພາບສັດ ແລະ ການຜະລິດອາຫານ. ເນ...
Antimicrobial resistance (AMR) has become a global public health concern and Lebanon is of no exception to this issue. The spread of antimicrobial-resistant bacteria is considered an alarming public health threat, with a potential extent similar to global warming and other social and environmental t...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
The goals and objectives of the Sudan National Action Plan on AMR can only be achieved through implementing strategic interventions and activities with all concerned ministries and departments joining hands with other stakeholders to collaboratively tackle these challenges.
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
This brief considers the rationale for shielding individuals at high risk of severe disease or death from COVID-19 in low- and middleincome countries. It provides an overview of proposed approaches to shielding, discusses the categories of individuals who may be identified for shielding, and outline...
This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and understanding of AMR). It is targeted specifically at health educators and policy planners, and applies ...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Interim practical manual supporting implementation of the WHO guidelines on core components of infection prevention and control programmes
In India, in response to the above and guided by our counterparts in the government of India, the UN agencies have developed the Novel Coronavirus Disease Joint Health Response Plan by UN Agencies and Partners, led by WHO-India, in close collaboration with the Ministry of Health and Family Welfare, ...
Malaria Journal (2018) 17:460 https://doi.org/10.1186/s12936-018-2606-9
In malaria endemic countries, asymptomatic cases constitute an important reservoir of infections sustaining transmission. Estimating the burden of the asymptomatic population and identifying areas with elevated risk is import...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
The publication provides an overview and analysis of international instruments that set standards related to the use of antimicrobials across the human, animal and plant sectors, and their release into the environment. The purpose of the document is to identify existing instruments and standards in ...
